Skip to content
10-Q

Quarterly Report

DEXCOM INC DXCM

0001093557-26-000073

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 23, 2026 385.87M sh
Shares Diluted Q1 2026 · Mar 31, 2026 393.6M sh
Shares Diluted Q1 2026 · Mar 31, 2025 407.5M sh
Capex Q1 2026 · Mar 31, 2026 $76.6M
Capex Q1 2026 · Mar 31, 2025 $87M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $525.6M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $183.8M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.12B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $917.7M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $904.9M
Stockholders Equity Q1 2026 · Mar 31, 2026 $2.96B
Stockholders Equity Q1 2026 · Dec 31, 2025 $2.75B
Stockholders Equity Q1 2026 · Mar 31, 2025 $2.27B
Stockholders Equity Q1 2026 · Dec 31, 2024 $2.1B
Current Liabilities Q1 2026 · Mar 31, 2026 $2.22B
Current Liabilities Q1 2026 · Dec 31, 2025 $2.14B
Total Liabilities Q1 2026 · Mar 31, 2026 $3.68B
Total Liabilities Q1 2026 · Dec 31, 2025 $3.59B
Current Assets Q1 2026 · Mar 31, 2026 $4.33B
Current Assets Q1 2026 · Dec 31, 2025 $4.03B
Total Assets Q1 2026 · Mar 31, 2026 $6.63B
Total Assets Q1 2026 · Dec 31, 2025 $6.34B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.51
Eps Diluted Q1 2026 · Mar 31, 2025 $0.27
Eps Basic Q1 2026 · Mar 31, 2026 $0.52
Eps Basic Q1 2026 · Mar 31, 2025 $0.27
Sga Expense Q1 2026 · Mar 31, 2026 $349.7M
Sga Expense Q1 2026 · Mar 31, 2025 $310.1M
Rd Expense Q1 2026 · Mar 31, 2026 $145.3M
Rd Expense Q1 2026 · Mar 31, 2025 $145.2M
Net Income Q1 2026 · Mar 31, 2026 $199.5M
Net Income Q1 2026 · Mar 31, 2025 $105.4M
Operating Income Q1 2026 · Mar 31, 2026 $255.3M
Operating Income Q1 2026 · Mar 31, 2025 $133.7M
Gross Profit Q1 2026 · Mar 31, 2026 $750.3M
Gross Profit Q1 2026 · Mar 31, 2025 $589M
Revenue Q1 2026 · Mar 31, 2026 $1.19B
Revenue Q1 2026 · Mar 31, 2025 $1.04B